Novartis India bulk deals, insider trading and stake changes
NSE: NOVARTINDBSE: 500672Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,684.50.
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹4,505 Cr1,055th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 23 Jul 2026
- 46.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 5.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 23 Jul 2026
- 12.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 23 Jul 2026
- 12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,46,21823.7% delivered
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Novartis India promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade · 1 off-market move
Novartis India insider trading
All 3 disclosures on record.Insider trading, all companies
Jul 2026
- NOVARTIS AG₹1,377 Cr1,74,50,680 sharesGave · Promoter · 29 Jul 2026 · Off Market · held 1,74,50,680 before, holds none after
Jan 2018
- Novartis A G Revised₹215 Cr32,05,362 sharesGave · Promoter · 23 Jan 2018 · disclosed 24 Jan · Buy-back Offer · held 2,06,56,042 before, holds 1,74,50,680 after
Sep 2016
- Novartis AG33,14,555sharesSold · Promoter · 16 Sep 2016 · held 2,39,70,597 before
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Novartis India stake sales and purchases
All 7 disclosures on record.
Jul 2026
- SoldNovartis AG · promoter70.68% of the company1,74,50,680 shares29 Jul 2026 · filed under the 2% rule · Off Market
- AcquiredWaveRise Investments Ltd & Others · promoter70.68% of the company1,74,50,680 sharesholds 70.68% after29 Jul 2026 · filed under the 5% rule · Off Market
Jan 2018
- SoldNovartis AG · promoter11.39% of the company32,05,362 sharesholds 70.68% after23 Jan 2018 · filed under the 2% rule · Buy-back Offer
Jun 2009
- SoldLife Insurance Corporation of India5.67% of the company18,10,772 shares19 Jun 2009 · filed under the 1997 takeover rules · Open Offer
Dec 2008
- AcquiredRELIANCE LONG TERM EQUITY FUND0.03% of the company10,000 sharesholds 5.02% after31 Dec 2008
- AcquiredRELIANCE MUTUAL FUND0.03% of the company10,000 sharesholds 5.02% after31 Dec 2008
Dec 2006
- AcquiredLIFE INSURANCE CORPN OF INDIA0.06% of the company1,00,000 sharesholds 5.19% after6 Dec 2006
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Novartis India bulk deals
Last 12 months, since 23 Oct 2025: 2 bulk deals, ₹22 Cr bought and ₹22 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Monday 7 Sep 20262 firms · ₹22 Cr bought · ₹22 Cr soldNet nil
- BoughtKARAN BHAGATBought 1,30,000 at ₹1,670.520.53% of the company₹22 Cr
- SoldKYRUSH INVESTMENTSSold 1,30,000 at ₹1,670.500.53% of the company₹22 Cr
Thursday 16 Aug 20121 firm · ₹0 bought · ₹15 Cr soldNet sold ₹15 Cr
- SoldIDFC SMALL AND MIDCAP EQUITY SME FUNDSold 2,20,217 at ₹670.02₹15 Cr
Wednesday 29 Aug 20072 firms · ₹25 Cr bought · ₹25 Cr soldNet sold ₹0.14 Cr
- SoldICICI PRUDENTIAL ASSET MANAGEMENT CO.LTD.Sold 9,23,800 at ₹269.02₹25 Cr
- BoughtRELIANCE CAPITAL TRUSTEE CO.LTD.Bought 9,18,831 at ₹269.00₹25 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 5 deals on record from 4 Jan 2004.